"Graves Ophthalmopathy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An autoimmune disorder of the EYE, occurring in patients with Graves disease. Subtypes include congestive (inflammation of the orbital connective tissue), myopathic (swelling and dysfunction of the extraocular muscles), and mixed congestive-myopathic ophthalmopathy.
| Descriptor ID |
D049970
|
| MeSH Number(s) |
C11.270.842 C11.675.349.500.500 C19.874.283.605.500 C19.874.397.370.500 C20.111.555.500
|
| Concept/Terms |
Graves Ophthalmopathy- Graves Ophthalmopathy
- Ophthalmopathy, Graves
- Ophthalmopathies, Thyroid-Associated
- Ophthalmopathies, Thyroid Associated
- Thyroid-Associated Ophthalmopathies
- Thyroid Associated Ophthalmopathies
- Thyroid-Associated Ophthalmopathy
- Thyroid Associated Ophthalmopathy
- Dysthyroid Ophthalmopathy
- Dysthyroid Ophthalmopathies
- Ophthalmopathies, Dysthyroid
- Ophthalmopathy, Dysthyroid
- Ophthalmopathy, Thyroid-Associated
- Ophthalmopathy, Thyroid Associated
Myopathic Ophthalmopathy- Myopathic Ophthalmopathy
- Myopathic Ophthalmopathies
- Ophthalmopathies, Myopathic
- Ophthalmopathy, Myopathic
Congestive Ophthalmopathy- Congestive Ophthalmopathy
- Congestive Ophthalmopathies
- Ophthalmopathies, Congestive
- Ophthalmopathy, Congestive
- Ophthalmopathy, Infiltrative
- Infiltrative Ophthalmopathies
- Infiltrative Ophthalmopathy
- Ophthalmopathies, Infiltrative
- Edematous Ophthalmopathy
- Edematous Ophthalmopathies
- Ophthalmopathies, Edematous
- Ophthalmopathy, Edematous
|
Below are MeSH descriptors whose meaning is more general than "Graves Ophthalmopathy".
Below are MeSH descriptors whose meaning is more specific than "Graves Ophthalmopathy".
This graph shows the total number of publications written about "Graves Ophthalmopathy" by people in this website by year, and whether "Graves Ophthalmopathy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2021 | 6 | 0 | 6 |
| 2024 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Graves Ophthalmopathy" by people in Profiles.
-
Effects of Teprotumumab and Role of Human Leukocyte Antigens Markers in Patients With Thyroid Eye Disease. Endocr Pract. 2024 Nov; 30(11):1038-1043.
-
Orbital decompression following treatment with teprotumumab for thyroid eye disease. Can J Ophthalmol. 2025 Feb; 60(1):e59-e64.
-
Teprotumumab for Thyroid Eye Disease-related Strabismus. Ophthalmic Plast Reconstr Surg. 2024 Jul-Aug 01; 40(4):434-439.
-
Oral Doxycycline for Mild Thyroid Eye Disease. JAMA Ophthalmol. 2022 11 01; 140(11):1083-1084.
-
Orbital Radiation for Thyroid Eye Disease: A Report by the American Academy of Ophthalmology. Ophthalmology. 2022 04; 129(4):450-455.
-
Extrathyroidal Manifestations of Thyroid Disease: Graves Eye Disease. Neuroimaging Clin N Am. 2021 Aug; 31(3):367-378.
-
Rapidly progressive cognitive decline associated with teprotumumab in thyroid eye disease. BMJ Case Rep. 2021 May 10; 14(5).
-
Supraorbital Neuralgia Associated With Thyroid Eye Disease. Ophthalmic Plast Reconstr Surg. 2021 May-Jun 01; 37(3):230-235.
-
Thyroid Eye Disease: Current Concepts and State of the Art Treatment. Int Ophthalmol Clin. 2021 04 01; 61(2):1-2.
-
Challenges of Managing Strabismus in Thyroid Eye Disease. Int Ophthalmol Clin. 2021 04 01; 61(2):107-125.